Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors.
Cucchi DGJ, Van Alphen C, Zweegman S, Van Kuijk B, Kwidama ZJ, Al Hinai A, Henneman AA, Knol JC, Piersma SR, Pham TV, Jimenez CR, Cloos J, Janssen JJWM.
Cucchi DGJ, et al. Among authors: knol jc.
Hemasphere. 2021 Jun 12;5(7):e606. doi: 10.1097/HS9.0000000000000606. eCollection 2021 Jul.
Hemasphere. 2021.
PMID: 34136754
Free PMC article.
No abstract available.